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Multivesicular bodyThe mechanism of membrane scission during inﬂuenza A virus budding has been the subject of con-
troversy. We conﬁrm that inﬂuenza M1 binds VPS28, a subunit of the ESCRT-1 complex. However, confocal
microscopy of infected cells showed no marked colocalisation between M1 and VPS28 or VPS4 ESCRT
proteins, or relocalisation of the cellular proteins. Trafﬁcking of HA and M1 appeared normal when
endosomal sorting was impaired by expression of inactive VPS4. Overexpression of either isoform of VPS28
or wildtype or dominant negative VPS4 proteins did not alter production of ﬁlamentous virions. SiRNA
depletion of endogenous VPS28 had no signiﬁcant effect on inﬂuenza virus replication. Furthermore, cells
expressing wildtype or dominant-negative VPS4 replicated ﬁlamentous and non-ﬁlamentous strains of
inﬂuenza to similar titres, indicating that inﬂuenza release is VPS4-independent. Overall, we see no role for
the ESCRT pathway in inﬂuenza virus budding and the signiﬁcance of the M1–VPS28 interaction remains to
be determined.© 2009 Elsevier Inc. All rights reserved.Introduction
A member of the Orthomyxoviridae family, inﬂuenza A virus can
form two morphologically distinct types of enveloped particles;
spherical and ﬁlamentous virions (Mosley and Wyckoff, 1946).
Filamentous inﬂuenza particles have the same diameter as spherical
ones (approximately 100 nm) but can reach over 30 μm in length
(Roberts and Compans, 1998). Both types of virion contain the same
set of viral proteins: the haemagglutinin (HA) and neuraminidase
(NA) glycoproteins, and M2 ion channel embedded in the host-
derived lipid bilayer, surrounding an internal layer of the M1 matrix
protein which in turn encapsidates the genomic ribonucleoproteins
(RNPs) along with small quantities of the NS2/NEP protein (Cheung
and Poon, 2007). Individual strains of inﬂuenza virus vary in whether
they produce only spherical or a mixture of spherical and ﬁlamentous
particles, with the loss of ﬁlamentous virus formation being associated
with adaptation to growth in eggs (Choppin and Tamm, 1960;
Kilbourne and Murphy, 1960). Virion morphology is determined by
a combination of viral genetics and cellular factors. M1 is the major.
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ll rights reserved.determinant of particle shape (Bourmakina and Garcia-Sastre, 2003;
Elleman and Barclay, 2004) although other virus genes also play a role
(Jin et al., 1997; Mitnaul et al., 1996; Roberts et al., 1998; Smirnov Yu et
al., 1991). In the laboratory, polarised epithelial cells produce more
ﬁlamentous virus than non-polarised cells, potentially due to the
organisation of the actin cytoskeleton (Roberts and Compans, 1998;
Simpson-Holley et al., 2002). However, cells with an intermediate
epithelioid phenotype such as 293T cells, that do not possess fully
differentiated apical and basolateral plasma membrane surfaces but
grow in adherent sheets are able to support ﬁlament production (data
not shown).
Whether the mature virion is ﬁlamentous or spherical, its ﬁnal
release requires ‘pinching off’ of the viral envelope from the plasma
membrane.While it seems probable that cellular proteins are involved
in this ﬁnal membrane scission step, this issue has not yet been
resolved. Thematrix proteins ofmany other enveloped viruses contain
‘late domains’; short interchangeable peptidemotifs that interact with
and co-opt the cellular Endosomal Sorting Complex Required for
Transport (ESCRT) system in order to bud outwards from the plasma
membrane (reviewed in Morita and Sundquist, 2004). The ESCRT
pathway comprises four multi-protein complexes (termed ESCRT-0 to
ESCRT-III) that are normally involved in membrane remodelling
processes such as multivesicular body (MVB) biogenesis and
cytokinesis (Stuffers et al., 2008). ESCRT proteins were originally
identiﬁed in yeast in screens for genes affecting protein trafﬁcking to
the vacuole (vacuole protein sorting, VPS genes) (Bankaitis et al.,
269E.A. Bruce et al. / Virology 390 (2009) 268–2781986; Rothman and Stevens, 1986). Mutation of the class E group of
VPS genes results in a phenotype whereby proteins accumulate in a
large, aberrant endosomal compartment adjacent to the vacuole
(Raymond et al., 1992). Later work established that the ESCRT
machinery is highly conserved from yeast to man (Katzmann et al.,
2001). ESCRTs play an important role in trafﬁcking ubiquitinated
proteins from endosomes to lysosomes for degradation, by recognis-
ing the ubiquitin signal and targeting the protein for inclusion into the
inward-budding vesicles of the MVB. ESCRTs are also proposed to
function in the inward-budding process itself. As noted above, this
structural feature has been hijacked by several viruses for their ﬁnal
membrane scission step, either into an internal lumen, or from the
plasma membrane (Chen and Lamb, 2008). Viruses known to use the
ESCRT pathway include many retroviruses such as human immuno-
deﬁciency virus (HIV) (Garrus et al., 2001; Martin-Serrano et al.,
2001) and murine leukemia virus (MLV) (Garrus et al., 2001), as well
as viruses from other families such as vesicular stomatitis virus (Taylor
et al., 2007) and herpes simplex virus (HSV) (Crump et al., 2007).
Disruption of ESCRT function or mutation of viral late domains
generally prevents the separation of virions from the cell membrane,
often resulting in ‘daisy-chain’ or sometimes in ﬁlamentous particle
morphologies (Bieniasz, 2006). The striking similarities in virion
morphology of some HIV and MLV late domain mutants (Bieniasz,
2006; Yuan et al., 2000) and ﬁlamentous inﬂuenza virus particles
(Roberts and Compans, 1998; Simpson-Holley et al., 2002) prompted
us to hypothesise that inﬂuenza virus also used the ESCRT system to
bud, and that formation of ﬁlamentous viral particles was the result of
a reduced ability to engage ESCRT complexes. In initial support of this,
two studies suggested that inﬂuenza A M1 contained a ‘late domain’
that interacted with the ESCRT protein VPS28 to direct virus budding
(Hui et al., 2003, 2006a), while a further report from another
laboratory showed that a point mutation in the putative late domain
promoted the formation of ﬁlamentous particles (Burleigh et al.,Fig. 1. Interaction of M1 and VPS28 in vitro. (a) Radiolabelled in vitro translated PR8, Miami o
the PR8 M1 experiment) or (ii) autoradiography before (Total; note the predominant poly
indicated GST fusion proteins (28-1; VPS28-1, 28-2; VPS28-2, M1; GST-M1, NP; GST-NP) imm
M1 from the indicated strains of virus that bound to (b) 6 μg of GST-VPS28-1 or (c) the indi
plotted as the % of the input material. The mean and range of two independent experiment2005). However, much of the evidence supporting the use of the
ESCRT pathway by inﬂuenza rested on the behaviour of sets of
supposedly viable recombinant viruses which showed that, similarly
to other virus families, the inﬂuenza M1 late domain was replaceable
by alternative late domain sequences and could be moved elsewhere
in the protein. Unfortunately, the realisation that these viruses were in
fact WT inﬂuenza and the subsequent retraction of the papers by Hui
et al. (2006b) left the role of the ESCRT pathway in inﬂuenza virus
budding uncertain. Indeed, a later study examining the requirements
for budding of recombinant inﬂuenza A virus like particles (VLPs)
found that their production did not require a functional ESCRT
pathway (Chen et al., 2007).
Here, we further examine the interaction of inﬂuenza A virus with
the ESCRT pathway. We show that although the M1 protein binds
VPS28 protein in vitro, budding of both ﬁlamentous and non-
ﬁlamentous strains of virus is independent of VPS28 levels and a
functional VPS4 in epithelial and epithelioid cell lines.
Results
Interactions between the inﬂuenza A M1 protein and VPS28
Prompted by the publication (but prior to its retraction) of the
study by Hui et al. (2006a, 2006b) suggesting a functionally important
interaction between VPS28 and inﬂuenza A M1 involved in virus
budding, we set out to test the hypothesis that the strength of the
interaction between M1 and VPS28 controls virus particle morphol-
ogy by determining the efﬁciency with which nascent virions pinch
off from the plasma membrane. To this end, VPS28-1 and VPS28-2
isoforms were expressed and puriﬁed from Escherichia coli as
glutathione-S-transferase (GST) fusion proteins, as well as similar
fusion proteins containing the inﬂuenza A/PR/8/34 (PR8) M1 and NP
proteins (Fig. 1a, panel i). When the VPS28 constructs were tested forr Nkt 11 M1 proteins were analysed by SDS-PAGE and (i) Coomassie blue staining (from
peptide species in unfractionated reticulocyte lysate is globin) or after binding to the
obilised on glutathione sepharose. (b, c) The amounts of radiolabelled in vitro translated
cated amounts of GST-VPS28-1 or GST-VPS28-2 were determined by densitometry and
s is plotted in (b) while the results of a single experiment are shown in (c).
Fig. 2. Intracellular localisation of VPS28. 293T cells were transfected (or (e), mock transfected) with plasmids encoding (a–d) GFP-VPS28-1 or (f–j) GFP-VPS28-2 and 18 h later (a, f,
g) mock infected or (b–e, h–j) infected at an MOI of 2 with inﬂuenza viruses as labelled. At 8 h p.i. cells were ﬁxed, permeabilised, stained with the indicated antisera and DAPI and
imaged by confocal microscopy. The main images represent a 39.5 μm square window. Insets show higher magniﬁcation views of the areas indicated by white boxes.
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down” assays, both fusion proteins but not GST alone bound M1
with reasonable efﬁciency (Fig. 1a, panel ii; compare lanes 2–4).
Furthermore, the in vitro translated M1 bound to GST tagged VPS28-
1 with greater apparent afﬁnity than the positive controls, GST-M1
and GST-NP (Fig. 1a; compare lanes 3, 5 and 6). Having reproduced
an M1–VPS28 interaction in vitro, we next tested whether M1
polypeptides from ﬁlamentous and non-ﬁlamentous strains of virus
differed in their binding activity. As reagents, we had available the
M1 genes from two strains of equine inﬂuenza (A/eq/Newmarket/
11/03 (Nkt 11) and A/eq/Miami/63 (Miami)) for which reverse-
genetic analyses had established that they determined the respec-
tive ﬁlamentous and non-ﬁlamentous nature of the viruses (DE, EM
and PD, manuscript in preparation and see Fig. 6). Similar amounts
of the Miami and Nkt 11 matrix proteins bound to PR8 GST-M1 and
GST-NP as the homologous interaction (Fig. 1a, panels ii–iv, lanes 5
and 6). However, while the equine virus matrix proteins also bound
to the GST-VPS28 polypeptides, the interaction of the Nkt 11 protein
was noticeably reduced (lanes 3 and 4). In conﬁrmation of this,
when replicate experiments were quantiﬁed by densitometry, the
M1 proteins from the non-ﬁlamentous PR8 and Miami strains
bound to VPS28-1 with similar efﬁciency, with 0.7 μM VPS28
retaining around 20% of the in vitro translated M1 (Fig. 1b). In
contrast, the M1 protein from the ﬁlamentous Nkt 11 virus bound
signiﬁcantly less well, with less than 10% of the input material being
retained. To examine this in more detail, we titrated the binding
activity of both VPS28 isoforms for the equine inﬂuenza M1
polypeptides. Miami M1 bound to either isoform of VPS28 better
than the Nkt 11 M1 at all VPS28 concentrations tested, while VPS28-
1 showed higher afﬁnity for either M1 polypeptide than VPS28-2
(Fig. 1c). Thus in corroboration of the ﬁndings of Hui et al. (2006a),
we ﬁnd evidence for an interaction between inﬂuenza A M1 andFig. 3. Effect of GFP-VPS28 overexpression on viral ﬁlament production. MDCK cells were tran
with (a, b) PR8 or (c, d) PR8 MUd virus at an MOI of 5. Cells were ﬁxed after an overnight i
confocal microscopy. Images represent a 39.5 μm square window and are maximum intensVPS28 in vitro. Furthermore, this interaction shows virus strain and
isoform-dependent variation in strength.
Expression of HIV-1 Gag or Ebola virus VP40 induces the
relocalisation of VPS28-1 to the plasma membrane (Martin-Serrano
et al., 2003b; Silvestri et al., 2007). To further examine the role of
VPS28 in inﬂuenza infection we next investigated whether it
colocalised with the viral structural proteins and if its localisation
changed in response to infection. 293T cells were transfected with
plasmids encoding GFP-tagged VPS28-1 or -2, then infected or mock
infected with either non-ﬁlamentous (PR8) or ﬁlamentous (PR8
MUd; Noton et al., 2007) strains of inﬂuenza virus. At 8 h post
infection, cells were ﬁxed and the localisation of the ﬂuorescently
tagged VPS28 proteins as well as inﬂuenza proteins stained by
immunoﬂuorescence were visualised by confocal microscopy. No
antibody-dependent signal was seen from mock infected cells
stained with anti-HA (Figs. 2a, f) or M1 antibodies (Fig. 2g). In
most mock infected cells, GFP-VPS28-1 localised diffusely through-
out the cell, including both cytoplasm and nucleus (Fig. 2a), in
agreement with previously published data examining the intracel-
lular localisation of recombinant myc- or CFP-tagged VPS28 proteins
(Bishop and Woodman, 2001; Martin-Serrano et al., 2003b) as well
as untagged VPS28 (Silvestri et al., 2007). In a minority of cells,
bright cytoplasmic accumulations several microns across were
observed (data not shown, but see Fig. 3), reminiscent of the
swollen endosomes observed after expression of dominant negative
versions of the AAA-ATPase VPS4 (Bishop and Woodman, 2000;
Fujita et al., 2003); see also Figs 5 and 6. VPS28-1 localisation was
not discernibly altered by inﬂuenza virus infection, whether with
the non-ﬁlamentous PR8 or ﬁlamentous PR8 MUd strains of virus
(Figs. 2a–d). As expected, the viral HA protein localised at the
plasma membrane in cells infected with PR8; no speciﬁc colocalisa-
tion with the GFP VPS28-1 protein was observed (Fig. 2b). HAsfected with plasmids encoding GFP-VPS28-1 (a, c) or 28-2 (b, d) and 18 h later infected
ncubation and surface HA stained with anti-whole PR8 virus serum before imaging by
ity projections summing multiple Z-axis planes of focus across the depth of the cells.
Fig. 4. Role of VPS28 in virus replication. 293T cells were transfected with siRNAs
targeted against VPS28, the cellular housekeeping gene GAPDH, with a non-targeting
pool, or mock transfected (−), followed 48 h later by infection with inﬂuenza A virus.
(a) Cell lysates as well as aliquots of puriﬁed recombinant VPS28-1 were analysed 72 h
post transfection by western blotting with antisera against VPS28-1 (green) or as a
loading control, tubulin (red). MW; molecular mass markers (kDa). (b) VPS28 levels in
(a) were quantiﬁed by densitometry and normalised to tubulin levels. Plotted values
represent the mean+S.D. of three replicates of siRNA depletion of VPS28 relative to the
mean+S.D. amounts obtained from the control treatments in (a). (c) Virus released by
siRNA-treated cells was harvested at 24 h p.i. and titred by plaque assay. Values plotted
represent the mean+S.D. as detailed in (b).
272 E.A. Bruce et al. / Virology 390 (2009) 268–278localisation in cells over-expressing GFP VPS28-1 did not appear to
differ from that observed in cells infected with PR8 MUd (data not
shown), or in untransfected cells (Fig. 2e). Similarly, M1 protein
from both PR8 and PR8 MUd was found throughout the cell though
predominantly in the cytoplasm in a manner that did not
appreciably differ between GFP VPS28-1-transfected cells and
untransfected cells (Figs. 2c–e). While low magniﬁcation merged
images of superinfected GFP VPS28-1 transfections appeared to
reveal a degree of colocalisation between VPS28-1 and M1 proteins
resident in the cytoplasm and nucleus, inspection of higher
magniﬁcation images revealed that the M1 staining was more
granular than GFP VPS28-1 and the degree of true colocalisation
was poor (Fig. 2c, inset).
In uninfected cells transfected with GFP VPS28-2, two common
patterns of intracellular localisation were seen. In around half the
cells, the protein exhibited a diffuse cytoplasmic localisation with
exclusion from the nucleus (Fig. 2f), but large numbers of cells also
exhibited large cytoplasmic accumulations (Fig. 2g). These patterns
were also seen at similar frequencies in infected cells (Figs. 2h–j).
Furthermore, in neither case, did M1 show substantial amounts of
colocalisation with the ﬂuorescent VPS28-2. High magniﬁcation
examination of infected cells containing diffusely localised VPS28-2
showed that similarly to the case with VPS28-1, the cytoplasmic
puncta of M1 and VPS28-2 did not show a strong correlation (Fig.
2i, inset). Neither M1 (Figs. 2h, j) nor HA (data not shown)
appeared to be recruited to the aggregates present in many cells
over-expressing VPS28-2, suggesting that the HA and M1 proteins
are trafﬁcked to their normal cellular destinations even in the
presence of aggregated VPS28-2 protein. Overall therefore, despite
in vitro evidence for an M1–VPS28 interaction, the polypeptides
did not obviously inﬂuence each other's localisation in infected cells.
However, they were both clearly cytosolic, and so low levels of
colocalisation may be present.
Role of VPS28 in inﬂuenza A budding
Our hypothesis that the strength of the M1–VPS28 interaction
determines the efﬁciency with which virus buds and hence deter-
mines whether spherical or ﬁlamentous particles are formed predicts
that overexpression of VPS28 might affect the budding morphology of
the virus. Simply, supplying additional VPS28 might bias budding
towards production of spherical particles. Alternatively, as over-
expression of some ﬂuorescently tagged ESCRT proteins has been
shown to have trans-dominant inhibitory effects on viral budding
(Martin-Serrano et al., 2003a; von Schwedler et al., 2003), it was
possible that the opposite effect could be obtained, biasing virus
budding towards the production of ﬁlaments. To test these possibi-
lities, MDCK cells were transfected with GFP-VPS28 proteins, super-
infected with ﬁlamentous PR8 MUd or non-ﬁlamentous PR8 viruses
and surface HA localisation monitored by immunoﬂuoresence. In cells
infected with non-ﬁlamentous strains of virus, HA normally forms a
stippled pattern across the apical plasma membrane, whereas HA in
viral ﬁlaments forms readily visible micrometer length structures
(Roberts and Compans, 1998; Simpson-Holley et al., 2002). However,
cell surface HA remained in a stippled pattern in VPS28 transfected
cells infected with PR8 virus, even in cells where the foci of
overexpressed VPS28 polypeptide suggested that MVB trafﬁcking
was disrupted (Figs. 3a, b). Similarly, PR8MUd infected cells produced
abundant ﬁlaments regardless of transfection status, whether the
VPS28 polypeptide was diffusely localised or aggregated, or whether
isoform 1 or 2 was used (Figs. 3c, d). Thus surface HA localisation and
viral ﬁlament formation is apparently independent of GFP-VPS28
overexpression.
As the above data relied on overexpression of GFP-tagged
constructs, we next explored the role of endogenous VPS28. To
examine further any role VPS28 might play in inﬂuenza infection,siRNA treatment was used to knock down endogenous VPS28
expression and virus replication monitored. Triplicate wells of 293T
cells were transfected with siRNA sequences directed against
VPS28, or, as controls, with siRNAs targeted against the cellular
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), a pool of non-targeting siRNA sequences, or mock
transfected without siRNA. The cells were infected with PR8 virus
48 h post transfection and a further 24 h later replicated virus was
collected and titred by plaque assay while cell lysates were
harvested for western blot analysis of VPS28 levels. A polypeptide
with the same apparent molecular weight as puriﬁed recombinant
VPS28 was seen in all samples from control cells (Fig. 4a, lanes 2, 4
and 6) that was much reduced in quantity in cells treated with
siRNA against VPS28 (lanes 3, 5 and 7), indicating successful
knockdown of endogenous VPS28-1. The amount of VPS28-1
protein detected by western blotting was quantiﬁed by densito-
metry and normalised to tubulin levels, revealing over a 70%
reduction in levels after siRNA treatment (Fig. 4b). However, both
control and VPS28 siRNA-treated cells supported high levels of
virus replication, producing titres of more than 107 PFU/ml,
although the titres from the VPS28 depleted cells were marginally
(less than 50%) lower (Fig. 4c). Similar results were obtained from
a replicate experiment (data not shown) and overall, although
virus replication was consistently around 2-fold lower in VPS28
depleted cells, the difference was not statistically signiﬁcant
(unpaired two tailed t-test, N=6). We conclude that inﬂuenza
virus release either occurs in a VPS28-independent manner, or that
only small quantities of VPS28 are needed. However, taken toge-
ther with the ﬂuorescence microscopy data showing no substantial
273E.A. Bruce et al. / Virology 390 (2009) 268–278colocalisation between VPS28 and M1 (Fig. 2), or an effect of
VPS28 overexpression on the morphology of virus budding (Fig. 3),
no obvious role for VPS28 in inﬂuenza infection was apparent.
Role of VPS4 in inﬂuenza A budding
Since we found no obvious role for VPS28 in inﬂuenza virus
budding, we next examined the role of downstream elements of
the ESCRT pathway in this process. VPS4 plays a critical role in a
ﬁnal step of protein sorting into the intralumenal vesicles of
MVBs; the dissociation of the ESCRT complexes from the
membrane (Williams and Urbe, 2007). VPS4 is also required for
successful budding of viruses containing all currently identiﬁed
late domain motifs (Morita and Sundquist, 2004). Accordingly,
microscopy was ﬁrst used to test for colocalisation between VPS4
and viral proteins HA and M1 in the presence or absence of a
functional ESCRT pathway. Stably transfected 293 cell lines were
induced to express GFP-tagged fusion proteins of either WT VPS4
or a trans-dominant ATPase defective VPS4 EQ mutant by the
addition of ponasterone A (Crump et al., 2007) and after an
overnight incubation, infected (or mock infected) with PR8 virus.
At 8 h post infection cells were ﬁxed and stained for HA or M1. In
mock infected cells, the ﬂuorescently tagged WT VPS4 protein
showed a diffuse, mostly cytoplasmic localisation (Fig. 5a), while
the dominant negative mutant, VPS4 EQ, formed the characteristic
bright cytoplasmic aggregates of protein seen by others (Fig. 5b)
(Bishop and Woodman, 2000; Crump et al., 2007; Fujita et al.,
2003). Mock infected cells did not stain strongly with either anti-
M1 or anti-HA sera (Figs. 5a and b respectively). Infection with
PR8 virus did not result in appreciable redistribution of either WT
or EQ VPS4 with the functional version of the protein remaining in
a diffuse, largely cytoplasmic staining pattern while the trans-
dominant inhibitor still formed prominent cytoplasmic aggregatesFig. 5. Intracellular localisation of VPS4 and inﬂuenza polypeptides. 293 cell lines expressing
with PR8 virus at an MOI of 2 as labelled, ﬁxed and stained for the indicated viral antigens(Figs. 5c–f). Inﬂuenza M1 also showed the expected cytoplasmic
staining pattern in cells expressing the WT GFP-VPS4 fusion
polypeptide and although some apparent colocalisation could be
seen (Fig. 5c), inspection of higher power images showed that as
with VPS28 (Fig. 2), this primarily reﬂected the fact that both
polypeptides were largely cytoplasmic rather than true colocalisa-
tion of discrete ﬂuorescent foci (data not shown). Similarly, while
in some cells, a superﬁcial level of WT VPS4-HA colocalisation in
the peri-nuclear region was apparent, inspection of higher
magniﬁcation images revealed that the two proteins were localised
in juxtaposed structures rather than displaying convincing coin-
cidence (Fig. 5e, inset). Furthermore, the localisation of M1 and
HA was unaltered in cells expressing the dominant negative VPS4
EQ protein, with no visible recruitment of either viral polypeptide
to the disrupted MVBs (Figs. 5d, f). A similar outcome was
obtained when the ﬁlamentous PR8 MUd virus was used (data not
shown). Thus, overexpression of the wildtype or dominant
negative VPS4 protein did not perturb viral protein localisation
or trafﬁcking. Since expression of polypeptides from ESCRT-
dependent viruses often (though not always) results in relocalisa-
tion of ESCRT components and conversely, these viral polypeptides
relocalise in response to disruption of the ESCRT pathway (Calistri
et al., 2007; Martin-Serrano et al., 2001, 2003b; Medina et al.,
2005; Silvestri et al., 2007; Welsch et al., 2006), the failure to
observe similar outcomes with the major inﬂuenza virus structural
polypeptides does not support the hypothesis that inﬂuenza virus
budding involves the ESCRT pathway.
As we had originally hypothesised that modulation of the
interaction between virus and the cellular ESCRT pathway
determined whether or not virus budding produced ﬁlamentous
particles, MDCK cells were transfected with plasmids expressing
WT or EQ GFP-tagged VPS4, superinfected with a non-ﬁlamentous
reassortant PR8 virus containing segment 7 from A/eq/Miami/63WTor EQ mutant VPS4 proteins fused to GFP were infected (c–f) or mock infected (a, b)
and with DAPI at 8 h.p.i.
274 E.A. Bruce et al. / Virology 390 (2009) 268–278(PR8-Miami) or a ﬁlamentous reassortant containing segment 7
from A/eq/Newmarket/11/03 (PR8-Nkt 11) and stained for cell
surface HA in order to visualise ﬁlament formation. In cells over-
expressing WT VPS4, HA exhibited the expected localisation
patterns for a non-ﬁlamentous virus of punctate accumulation at
the apical cell surface in PR8-Miami infection (Fig. 6a) and long
ﬁlamentous particles extruding from the cell membrane in PR8-
Nkt11 infection (Fig. 6c). These patterns were not changed by
overexpression of the dominant negative VPS4 protein, with cells
infected with PR8-Miami exhibiting the same surface accumulation
seen in cells expressing the WT VPS4 protein (Fig. 6b) while cells
infected with PR8-Nkt11 still produced long ﬁlamentous structures
(Fig. 6d). Thus, overexpression of dominant negative VPS4 does not
induce the normally spherical PR8-Miami virus to produce
ﬁlamentous particles, while overexpression of WT VPS4 did not
prevent PR8-Nkt11 from forming ﬁlamentous particles.
The ability of the viral M1 and HA proteins to maintain their
normal localisation patterns in the absence of a functional ESCRT
pathway as well as the maintenance of ﬁlament formation
suggested that inﬂuenza budding itself may be VPS4 independent.
To test this hypothesis further, we examined the ability of the
VPS4 and VPS4 EQ cell lines to support inﬂuenza virus replication.
18 h post induction, cells were infected with either PR8, the
ﬁlamentous inﬂuenza virus strains PR8 MUd or A/Udorn/72
(Udorn), or herpes simplex virus type I (HSV). HSV was used as
a positive control, as it is known to require a functional VPS4
protein in order to undergo ﬁnal envelopment (Crump et al.,
2007). Induction of the GFP VPS4 proteins was veriﬁed by
observing levels of GFP signal at 18 h post induction (data not
shown). At 24 h p.i., viral supernatants were harvested and titred.
In cells expressing WT VPS4, HSV replicated to high titres ofFig. 6. Effect of YFP-VPS4 overexpression on viral ﬁlament production. MDCK cells were tran
mutant (b, d), incubated overnight and then infected with (a, b) PR8-Miami or (c, d) PR8-Nk
stained with anti-PR8 serum before imaging by confocal microscopy. Images represent a 39
planes of focus across the depth of the cells.greater than 107 pfu/ml. However, as expected (Crump et al.,
2007) cells expressing the non-functional VPS4 EQ protein
produced nearly 400-fold less virus (Fig. 7a), thus conﬁrming
that the VPS4 EQ cell line was behaving as expected. Inﬂuenza PR8
virus also replicated well in WT GFP-VPS4 expressing cells,
producing on average 2×107 pfu/ml, while PR8 MUd and Udorn
replicated rather less well, producing titres of only around 105 pfu/
ml. Reduced growth in tissue culture of ﬁlamentous inﬂuenza
viruses is a feature that has been seen before (Roberts and
Compans, 1998). However, similar titres of all three viruses were
produced from VPS4 EQ cell lines, and statistical analysis (unpaired
t-test) showed no signiﬁcant difference between the titres
produced in VPS4 WT as compared to VPS4 EQ cells (Fig. 7a). As
these results examined the release of virus from a single round of
high multiplicity infection, we next examined the kinetics of viral
growth in low multiplicity multi-cycle infections over a longer time
course. Under these conditions, HSV replication was effectively
blocked in cells expressing the VPS4 EQ protein (Fig. 7b). In
contrast, both ﬁlamentous Udorn and non-ﬁlamentous PR8 viruses
replicated to titres of more than 106 PFU/ml in both cell lines (Fig.
7c). At most time points with both inﬂuenza viruses, titres
released from cells expressing the VPS4 EQ protein were generally
slightly lower than from the WT cells. This was most noticeable at
24 h.p.i. in Udorn-infected cells, where an approximately ten-fold
reduction in titre released was apparent. However, the ﬁnal end
point titres of both viruses in both cell types were very similar.
Bearing in mind the substantial cytotoxicity of the VPS4 EQ protein
and contrasted with the almost complete failure of HSV to
replicate, this shows at best only a minor role for the ESCRT
pathway in inﬂuenza virus budding. Overall, from these data, as
well as the preceding experiments, we conclude that inﬂuenzasfected with plasmids encoding WT YFP-VPS4 (a, c) or the trans-dominant YFP-VPS4 EQ
t 11 virus at an MOI of 5. Cells were ﬁxed after an overnight incubation and surface HA
.5 μm square window and are maximum intensity projections summing multiple Z-axis
Fig. 7. Effect of the trans-dominant VPS4 EQmutant on inﬂuenza virus and HSV release. 293 cell lines expressingWTor EQmutant VPS4 proteins fused to GFP were infectedwith PR8,
Udorn or PR8 MUd inﬂuenza viruses at (a) an MOI of 2 or with HSV at an MOI of 5. 24 h p.i., the titres of released virus were determined by plaque assay. Plotted values represent the
mean and range of two (PR8 MUd, Udorn) or three (PR8) independent experiments or two replicates within a single experiment (HSV). (b, c) Cells were infected with PR8 or Udorn
inﬂuenza viruses at an MOI of 0.005 (c) or with HSV at an MOI of 0.05 (b). The titres of virus released at the indicated h.p.i. were determined by plaque assay. The mean and range of
two replicate experiments are plotted for PR8 and HSV while the mean±SEM of four replicates from two independent experiments are plotted for Udorn virus.
275E.A. Bruce et al. / Virology 390 (2009) 268–278virus assembly and budding, whether of spherical or ﬁlamentous
particles, occurs independently of the ESCRT pathway.
Discussion
Previous reports suggested that the inﬂuenza A virus matrix
protein contained a late domain that interacted with VPS28, a
cellular protein in the ESCRT-I complex (Hui et al., 2003, 2006a).
This prompted us to hypothesise that inﬂuenza particle shape
might be controlled by the strength of the interaction between the
M1 protein and the ESCRT machinery. In support of this, we found
that in vitro, the matrix proteins from two strains of non-
ﬁlamentous inﬂuenza virus bound well to VPS28-1 while an M1
polypeptide from a ﬁlamentous strain of virus bound less strongly
(Fig. 1). However, while our studies were in progress, the Hui
papers were retracted when the supposedly viable late domain
mutants were found to contain wildtype virus genomes (Hui et al.,
2006b), leaving the fundamental mechanism of inﬂuenza virus
budding unclear. This accords with our own data, in that we were
unable to rescue viruses with alternative ‘late domain’ sequences
(data not shown). Subsequent work showed that expression of a
variety of dominant negative VPS4 proteins had no effect on
inﬂuenza VLP release (Chen et al., 2007), arguing against a role for
the ESCRT system. However, as we had found independent support
for an interaction between M1 and the VPS28 subunit of the
ESCRT-I complex, and the role of VPS4 in the morphogenesis and
budding of authentic inﬂuenza virus particles (as opposed to
recombinant VLPs) had not been explored, there was a clear
rationale for studying the participation of the ESCRT pathway in
inﬂuenza budding in greater detail.
Despite the positive ﬁnding of an interaction between M1 and
VPS28, the rest of our ﬁndings were largely negative. Confocal
microscopy of infected cells found no great degree of colocalisation
or redistribution between the major inﬂuenza virus structural
proteins and the ESCRT components under study. Overexpression of
either VPS28 isoform, VPS4 or VPS4 EQ had no visible effect on the
production of ﬁlamentous viral particles. SiRNA-mediated depletion
of endogenous VPS28 had no signiﬁcant effect on the titre of viral
replication. Infection of stable cell lines expressing WT or trans-
dominant VPS4 with either spherical or ﬁlamentous inﬂuenza viruses
showed that viral output was not dependent on the presence of a
functional VPS4 protein. Overall therefore, in agreement with the
conclusions of Chen et al. (2007) regarding the lack of involvement of
VPS4 in inﬂuenza VLP production, we ﬁnd no obvious role for theESCRT pathway in the release of authentic inﬂuenza virus particles,
whether spherical or ﬁlamentous.
However, several aspects of these negative ﬁndings deserve
further consideration. Little characterisation of the VPS28-2 isoform
has been reported, beyond the sequence of its encodingmRNA and the
notation that it is a minor isoform (NCBI entry NM_016208).
Consistent with this, we were unable to detect a polypeptide with
the expected electrophoretic mobility for VPS28-2 in cell lysates (Fig.
4). Although we have not formally tested it, we predict that our
polyclonal anti-VPS28-1 serumwould cross-react with VPS28-2 as the
proteins share 183 common amino-acids out of 221/233 residues in
total. However, characterisation of GFP-tagged VPS28-1 and VPS28-2
showed that intracellular localisation of the proteins differed between
isoforms (Fig. 2). That observed for GFP VPS28-1 was similar to the
pattern reported for tagged and untagged forms of VPS28 (Bishop and
Woodman, 2001; Martin-Serrano et al., 2003b; Silvestri et al., 2007),
but the distribution of VPS28-2 was noticeably different both for its
exclusion from the nucleus and its increased propensity to form large
cytoplasmic protein aggregates. It is difﬁcult to say whether the
aggregates are indicative of the endogenous protein localisation. On
one hand, it is possible that overexpression (perhaps combined with
fusion of the GFP ﬂuorophore), is interfering with normal VPS28-2
function to the extent that the protein has become trans-dominant
and (much like VPS4 EQ), is inducing the formation of enlarged
endosomes and disrupting the ESCRT pathway. However, VPS28-2
differs from VPS28-1 in lacking the C-terminal 38 amino-acids present
in the dominant isoform and having a larger, alternative 50 residue
tail. The C-terminal domain of VPS28-1 is involved in interactions with
the downstream ESCRT II complex via VPS20 (Pineda-Molina et al.,
2006; Teo et al., 2006) so it is therefore possible that endogenous
VPS28-2 has inhibitory properties in the ESCRT pathway.
Depletion of VPS28-1 to roughly 30% of endogenous levels had no
signiﬁcant effect on inﬂuenza virus replication in experiments we
performed (Fig. 4). Additionally, we predict that the siRNAs used
would knock down expression of VPS28-2 as well, due to the sequence
similarity between the two isoforms. Two independent siRNA
experiments, each containing three replicates, were carried out.
Statistical analysis of data from the amalgamated experiments
revealed no signiﬁcant difference in viral titre from cells depleted of
VPS28 and those receiving control treatments. While we cannot rule
out the possibility that more efﬁcient knockdown of VPS28 expression
would reveal an inhibitory effect on inﬂuenza virus replication, taken
together with the lack of effect of GFP-VPS28 overexpression on
ﬁlamentous virus production and the low degree of colocalisation
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suggests that overall, VPS28 is not critical for virus replication in
cultured cells. The question therefore arises as to the signiﬁcance of
the interaction we observe between the two proteins (Fig. 1). A
negative interpretation would be that it is simply an in vitro
association between two proteins with overall opposing charges
(M1 pI=9.4 versus VPS28-1 pI=5.5). Consistent with a charge-
based interaction, VPS28-2 has a much more basic C-terminal
domain than VPS28-1 and it bound M1 markedly less well (Fig. 1c).
On the other hand, there are only 4 amino-acid differences between
the M1 proteins of Miami and Nkt11 viruses (DE, PD; unpublished
data) with no resulting charge differential, so the lower binding
afﬁnity of the Nkt11 M1 protein argues for a degree of speciﬁcity to
the interaction. A more interesting hypothesis therefore, is that the
in vitro interaction reﬂects a viral adaptation of little signiﬁcance to
replication in tissue culture but potentially greater signiﬁcance in
the multicellular host. Given the lack of evidence for the involve-
ment of the ESCRT pathway in inﬂuenza virus budding (Chen et al.,
2007; this study), we speculate that the M1–VPS28 interaction
functions in another pathway than MVB sorting. There is evidence
for additional roles of ESCRT proteins in cellular processes such as
mRNA transport, signalling, autophagy and cytokinesis (Carlton and
Martin-Serrano, 2007; Giebel and Wodarz, 2006; Pilecka et al.,
2007; Rusten and Simonsen, 2008; Sevrioukov et al., 2005), so this
is not implausible.
As the ESCRT system plays a crucial role in the budding of many
viruses, it is clearly useful to identify those, such as inﬂuenza, that
are able to bud independently of this pathway. The search for other
cellular proteins that can facilitate this ﬁnal pinching off process is
an important one for both cell biologists and virologists. Although
inﬂuenza does not appear to use the ESCRT system, it is likely that
there are other cellular proteins involved. Proteins containing Bin-
Amphiphysin-Rvs (BAR) domains have been implicated in inducing
membrane curvature during viral budding (Wang et al., 2003).
Additionally, recent computer modelling simulations suggest that
spontaneous vesicle formation can occur. In this scenario, protein
aggregation at speciﬁc sites on the plasma membrane and a
hydrophilic attraction between proteins and their immediate lipid
surroundings is able to drive membrane curvature in the absence
of inter-protein interactions (Reynwar et al., 2007). However,
membrane curvature alone is not enough to account for the
formation of completely budded vesicles, indicating that as-of-yet
unidentiﬁed cellular proteins might be involved in the ﬁnal steps of
the budding process ﬁlled for other viruses by VPS4 (Chen and
Lamb, 2008). Respiratory syncytial virus also buds through a VPS4-
independent pathway and it was recently shown that here,
budding is controlled by Rab11-FIP2 (Utley et al., 2008). It is
hoped that advances in mass spectrometry and large-scale
proteomic screening will be able to identify possible cellular
cofactors for inﬂuenza budding.
Materials and methods
Cells, viruses, plasmids and antisera
Human embryonic kidney 293T cell line, Madin–Darby Canine
Kidney (MDCK) cells and African green monkey kidney Vero cells
were cultured as previously described (Carrasco et al., 2004; Crump et
al., 2007). 293 cell lines that inducibly express GFP-VPS4A and GFP-
VPS4EQ proteins (Crump et al., 2007) were maintained in medium
supplemented with 0.2 mg/ml Zeocin (Invitrogen) and 0.4 mg/mL
G418 (PAA Laboratories GmbH). Expression of the GFP VPS4 proteins
was induced by adding 2.5 μg/ml Ponasterone A (Invitrogen) and
incubating for ∼18 h. Cells were transfected with plasmids using
Lipofectin or Lipofectamine 2000 (Invitrogen) according to the
manufacturer's instructions. For transfection of siRNAs, 293T cells(plated in a 6 well plate at 5×105 cells/well in 2 ml antibiotic free
media) were transfected approximately 18 h after seeding using
DharmaFECT transfection reagent (Dharmacon, 4 μl/well) to ﬁnal
siRNA concentration of 0.1 μM.
The Cambridge lineage of PR8 virus was propagated in embryo-
nated eggs as previously described (Elton et al., 2001), while for
experiments involving the growth of virus in cultured cells, A/Udorn/
72 (Simpson-Holley et al., 2002) or an MDCK-adapted version of PR8
rescued from plasmids (de Wit et al., 2004) and grown in MDCK cells
was used. A ﬁlamentous variant of PR8 containing segment 7 from A/
Udorn/72 (PR8 MUd) has been previously described (Noton et al.,
2007). Similar reverse-genetics strategies were used to create another
ﬁlamentous PR8 virus containing segment 7 from A/eq/Newmarket/
11/02 (PR8-Nkt11) as well as a non-ﬁlamentous reassortant (PR8-
Miami) with segment 7 from A/eq/Miami/63). HSV type I strain SC16
was propagated in Vero cells. For inﬂuenza virus infections (except
multi-cycle growth curves), virus was adsorbed to cells for 30 min in
Optimem medium at 37 °C before a 1 minute acid wash (10 mM HCl,
150 mM NaCl, pH 3) to remove residual inoculum followed by 3
washes with warm PBS and incubation in Optimem supplemented
with 1 μg/ml trypsin. HSV infections were performed similarly except
that medium containing serum was used and trypsin was omitted.
Inﬂuenza viruses were titred by plaque assay in MDCK cells
(Matrosovich et al., 2006) while HSV was titred by plaque assay in
Vero cells. Formulti-cycle growth curve infections, inﬂuenza viruswas
adsorbed to cells for 1 h in serum free media, then overlayed with
serum free media containing 1 μg/ml trypsin and 0.14% BSA.
Bacterial expression plasmids pGEX-NP and pGEX-M1 that express
PR8 NP orM1 respectively as GST fusion proteins have been previously
described (Digard et al., 1999; Noton et al., 2007). VPS28 variant 1
(VPS28-1) and variant 2 (VPS28-2) were ampliﬁed by PCR from
IMAGE clones 3535787 and 5741129, respectively, and subcloned into
pGEX4T-1 (GE Healthcare) for expression of GST fusion proteins; or
into pEGFP-C1 (Clontech) for the expression of N-terminally GFP-
tagged proteins in mammalian cells. Plasmids encoding yellow
ﬂuorescent protein (YFP)-tagged WT and dominant negative E228Q
(EQ) VPS4 proteins were generously supplied by Dr Juan Martin-
Serrano et al. (2003a).
Rabbit polyclonal antisera to whole PR8 virus and PR8 M1 have
been described previously (Amorim et al., 2007). Clone 6F6 anti-PR8
HA mouse monoclonal antibody was a gift from Dr Philip Stevenson.
To generate an anti-VPS28 serum, rabbits were immunised twice with
GST-VPS28-1 fusion protein followed by a ﬁnal boost with puriﬁed
recombinant VPS28-1 protein.
Protein analyses
GST fusion proteins were expressed in E. coli and puriﬁed as
previously described (Digard et al., 1999). To generate non-fused
VPS28-1, 500 μl samples of dialysed protein (∼0.1–0.2 mg) were
adjusted to 2.5 mM CaCl2 and cleaved with 3 U of thrombin at room
temperature for 6 h. GST was removed by binding to glutathione
sepharose, and protein-containing supernatant was lyophilised for
rabbit immunisation or use as molecular weight marker.
Radiolabelled proteins were in vitro translated in rabbit
reticulocyte and used in pull-down assays also as previously
described (Elton et al., 1999). For western blotting, samples were
separated by SDS-PAGE and transferred to nitrocellulose mem-
branes according to standard procedures. Blots were developed
using secondary antibodies conjugated to IR Dye 680 or 800 and
imaged and quantiﬁed on a LiCor Biosciences Odyssey near-infrared
imaging platform.
For ﬂuorescent microscopy, cells were ﬁxed with 4% formaldehyde
and processed for immunocytochemistry as previously described
(Elton et al., 2001; Simpson-Holley et al., 2002). Samples were imaged
using a Leica TCS SP confocal microscope. Post-capture processing of
277E.A. Bruce et al. / Virology 390 (2009) 268–278images to allow daylight visualisation and reproduction was applied
equally to each experiment using Adobe Photoshop.
Acknowledgments
We thank Drs Juan Martin-Serrano, Philip Stevenson and Janet
Daly for the gift of reagents. This work was supported by a grant from
the BBSRC (no. S18874) to PD. EAB is supported by a scholarship from
the Gates Cambridge Trust. SLN was supported by a BBSRC Committee
studentship. CMC is a Royal Society University Research Fellow.
References
Amorim, M.J., Read, E.K., Dalton, R.M., Medcalf, L., Digard, P., 2007. Nuclear export of
inﬂuenza A virus mRNAs requires ongoing RNA polymerase II activity. Trafﬁc
(Copenhagen, Denmark) 8 (1), 1–11.
Bankaitis, V.A., Johnson, L.M., Emr, S.D., 1986. Isolation of yeast mutants defective in
protein targeting to the vacuole. Proc. Natl. Acad. Sci. U. S. A. 83 (23), 9075–9079.
Bieniasz, P.D., 2006. Late budding domains and host proteins in enveloped virus release.
Virology 344 (1), 55–63.
Bishop, N., Woodman, P., 2000. ATPase-defective mammalian VPS4 localizes to aberrant
endosomes and impairs cholesterol trafﬁcking. Mol. Biol. Cell 11 (1), 227–239.
Bishop, N., Woodman, P., 2001. TSG101/mammalian VPS23 and mammalian VPS28
interact directly and are recruited to VPS4-induced endosomes. J. Biol. Chem. 276
(15), 11735–11742.
Bourmakina, S.V., Garcia-Sastre, A., 2003. Reverse genetics studies on the ﬁlamentous
morphology of inﬂuenza A virus. J. Gen. Virol. 84 (Pt 3), 517–527.
Burleigh, L.M., Calder, L.J., Skehel, J.J., Steinhauer, D.A., 2005. Inﬂuenza a viruses with
mutations in the m1 helix six domain display a wide variety of morphological
phenotypes. J. Virol. 79 (2), 1262–1270.
Calistri, A., Sette, P., Salata, C., Cancellotti, E., Forghieri, C., Comin, A., Gottlinger, H.,
Campadelli-Fiume, G., Palu, G., Parolin, C., 2007. Intracellular trafﬁcking and
maturation of herpes simplex virus type 1 gB and virus egress require functional
biogenesis of multivesicular bodies. J. Virol. 81 (20), 11468–11478.
Carlton, J.G., Martin-Serrano, J., 2007. Parallels between cytokinesis and retroviral
budding: a role for the ESCRT machinery. Science (New York, N.Y.) 316 (5833),
1908–1912.
Carrasco, M., Amorim, M.J., Digard, P., 2004. Lipid raft-dependent targeting of the
inﬂuenza A virus nucleoprotein to the apical plasma membrane. Trafﬁc (Copenha-
gen, Denmark) 5 (12), 979–992.
Chen, B.J., Lamb, R.A., 2008. Mechanisms for enveloped virus budding: can some viruses
do without an ESCRT? Virology 372 (2), 221–232.
Chen, B.J., Leser, G.P., Morita, E., Lamb, R.A., 2007. Inﬂuenza virus hemagglutinin and
neuraminidase, but not the matrix protein, are required for assembly and budding
of plasmid-derived virus-like particles. J. Virol. 81 (13), 7111–7123.
Cheung, T.K., Poon, L.L., 2007. Biology of inﬂuenza a virus. Ann. N.Y. Acad. Sci. 1102,
1–25.
Choppin, P.W., Tamm, I., 1960. Studies of two kinds of virus particles which comprise
inﬂuenza A2 virus strains. II. Reactivity with virus inhibitors in normal sera. J. Exp.
Med. 112, 921–944.
Crump, C.M., Yates, C., Minson, T., 2007. Herpes simplex virus type 1 cytoplasmic
envelopment requires functional Vps4. J. Virol. 81 (14), 7380–7387.
de Wit, E., Spronken, M.I., Bestebroer, T.M., Rimmelzwaan, G.F., Osterhaus, A.D.,
Fouchier, R.A., 2004. Efﬁcient generation and growth of inﬂuenza virus A/PR/8/34
from eight cDNA fragments. Virus Res. 103 (1–2), 155–161.
Digard, P., Elton, D., Bishop, K., Medcalf, E., Weeds, A., Pope, B., 1999. Modulation of
nuclear localization of the inﬂuenza virus nucleoprotein through interaction with
actin ﬁlaments. J. Virol. 73 (3), 2222–2231.
Elleman, C.J., Barclay, W.S., 2004. The M1 matrix protein controls the ﬁlamentous
phenotype of inﬂuenza A virus. Virology 321 (1), 144–153.
Elton, D., Medcalf, E., Bishop, K., Digard, P., 1999. Oligomerization of the inﬂuenza virus
nucleoprotein: identiﬁcation of positive and negative sequence elements. Virology
260 (1), 190–200.
Elton, D., Simpson-Holley, M., Archer, K., Medcalf, L., Hallam, R., McCauley, J., Digard, P.,
2001. Interaction of the inﬂuenza virus nucleoprotein with the cellular CRM1-
mediated nuclear export pathway. J. Virol. 75 (1), 408–419.
Fujita, H., Yamanaka, M., Imamura, K., Tanaka, Y., Nara, A., Yoshimori, T., Yokota, S.,
Himeno, M., 2003. A dominant negative form of the AAA ATPase SKD1/VPS4
impairs membrane trafﬁcking out of endosomal/lysosomal compartments: class E
vps phenotype in mammalian cells. J. Cell. Sci. 116 (Pt 2), 401–414.
Garrus, J.E., von Schwedler, U.K., Pornillos, O.W., Morham, S.G., Zavitz, K.H., Wang, H.E.,
Wettstein, D.A., Stray, K.M., Cote, M., Rich, R.L., Myszka, D.G., Sundquist, W.I., 2001.
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.
Cell 107 (1), 55–65.
Giebel, B., Wodarz, A., 2006. Tumor suppressors: control of signaling by endocytosis.
Curr. Biol. 16 (3), R91–R92.
Hui, E.K., Barman, S., Yang, T.Y., Nayak, D.P., 2003. Basic residues of the helix six domain
of inﬂuenza virus M1 involved in nuclear translocation of M1 can be replaced by
PTAP and YPDL late assembly domain motifs. J. Virol. 77 (12), 7078–7092.
Hui, E.K., Barman, S., Tang, D.H., France, B., Nayak, D.P., 2006a. YRKL sequence of
inﬂuenza virus M1 functions as the L domain motif and interacts with VPS28 and
Cdc42. J. Virol. 80 (5), 2291–2308.Hui, E.K., Barman, S., Yang, T.Y., Tang, D.H., France, B., Nayak, D.P., 2006b. Retraction.
J. Vir. 80 (20), 10289.
Jin, H., Leser, G.P., Zhang, J., Lamb, R.A., 1997. Inﬂuenza virus hemagglutinin and
neuraminidase cytoplasmic tails control particle shape. EMBO J. 16 (6), 1236–1247.
Katzmann, D.J., Babst, M., Emr, S.D., 2001. Ubiquitin-dependent sorting into the
multivesicular body pathway requires the function of a conserved endosomal
protein sorting complex, ESCRT-I. Cell 106 (2), 145–155.
Kilbourne, E.D., Murphy, J.S., 1960. Genetic studies of inﬂuenza viruses. I. Viral
morphology and growth capacity as exchangeable genetic traits. Rapid in ovo
adaptation of early passage Asian strain isolates by combination with PR8. J. Exp.
Med. 111, 387–406.
Martin-Serrano, J., Zang, T., Bieniasz, P.D., 2001. HIV-1 and Ebola virus encode small
peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.
Nat. Med. 7 (12), 1313–1319.
Martin-Serrano, J., Yarovoy, A., Perez-Caballero, D., Bieniasz, P.D., 2003a. Divergent
retroviral late-budding domains recruit vacuolar protein sorting factors by
using alternative adaptor proteins. Proc. Natl. Acad. Sci. U. S. A. 100 (21),
12414–12419.
Martin-Serrano, J., Zang, T., Bieniasz, P.D., 2003b. Role of ESCRT-I in retroviral
budding. J. Virol. 77 (8), 4794–4804.
Matrosovich, M., Matrosovich, T., Garten, W., Klenk, H.D., 2006. New low-viscosity
overlay medium for viral plaque assays. Virol. J. 3 (63).
Medina, G., Zhang, Y., Tang, Y., Gottwein, E., Vana, M.L., Bouamr, F., Leis, J., Carter, C.A.,
2005. The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle
release through pathways linked by Tsg101. Trafﬁc (Copenhagen, Denmark) 6 (10),
880–894.
Mitnaul, L.J., Castrucci, M.R., Murti, K.G., Kawaoka, Y., 1996. The cytoplasmic tail of
inﬂuenza A virus neuraminidase (NA) affects NA incorporation into virions, virion
morphology, and virulence in mice but is not essential for virus replication. J. Virol.
70 (2), 873–879.
Morita, E., Sundquist, W.I., 2004. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20,
395–425.
Mosley, V.M., Wyckoff, W.G.R., 1946. Electron micrography of the virus of inﬂuenza.
Nature 157 (263).
Noton, S.L., Medcalf, E., Fisher, D., Mullin, A.E., Elton, D., Digard, P., 2007. Identiﬁcation of
the domains of the inﬂuenza A virus M1 matrix protein required for NP binding,
oligomerization and incorporation into virions. J. Gen. Vir. 88 (Pt 8), 2280–2290.
Pilecka, I., Banach-Orlowska, M., Miaczynska, M., 2007. Nuclear functions of endocytic
proteins. Eur J. Cell Biol. 86 (9), 533–547.
Pineda-Molina, E., Belrhali, H., Piefer, A.J., Akula, I., Bates, P., Weissenhorn, W.,
2006. The crystal structure of the C-terminal domain of Vps28 reveals a con-
served surface required for Vps20 recruitment. Trafﬁc (Copenhagen, Denmark)
7 (8), 1007–1016.
Raymond, C.K., Howald-Stevenson, I., Vater, C.A., Stevens, T.H., 1992. Morphological
classiﬁcation of the yeast vacuolar protein sorting mutants: evidence for a
prevacuolar compartment in class E vps mutants. Mol. Biol. Cell 3 (12), 1389–1402.
Reynwar, B.J., Illya, G., Harmandaris, V.A., Muller, M.M., Kremer, K., Deserno, M., 2007.
Aggregation and vesiculation of membrane proteins by curvature-mediated
interactions. Nature 447 (7143), 461–464.
Roberts, P.C., Compans, R.W.,1998. Host cell dependence of viral morphology. Proc. Natl.
Acad. Sci. U. S. A. 95 (10), 5746–5751.
Roberts, P.C., Lamb, R.A., Compans, R.W., 1998. The M1 and M2 proteins of inﬂuenza A
virus are important determinants in ﬁlamentous particle formation. Virology 240
(1), 127–137.
Rothman, J.H., Stevens, T.H., 1986. Protein sorting in yeast: mutants defective in vacuole
biogenesismislocalize vacuolar proteins into the late secretory pathway. Cell 47 (6),
1041–1051.
Rusten, T.E., Simonsen, A., 2008. ESCRT functions in autophagy and associated disease.
Cell Cycle 7 (9), 1166–1172.
Sevrioukov, E.A., Moghrabi, N., Kuhn, M., Kramer, H., 2005. A mutation in dVps28
reveals a link between a subunit of the endosomal sorting complex required for
transport-I complex and the actin cytoskeleton in Drosophila. Mol. Biol. Cell 16 (5),
2301–2312.
Silvestri, L.S., Ruthel, G., Kallstrom, G., Warﬁeld, K.L., Swenson, D.L., Nelle, T., Iversen, P.L.,
Bavari, S., Aman, M.J., 2007. Involvement of vacuolar protein sorting pathway in
Ebola virus release independent of TSG101 interaction. J. Infect. Dis. 196 (Suppl 2),
S264–S270.
Simpson-Holley, M., Ellis, D., Fisher, D., Elton, D., McCauley, J., Digard, P., 2002. A
functional link between the actin cytoskeleton and lipid rafts during budding of
ﬁlamentous inﬂuenza virions. Virology 301 (2), 212–225.
Smirnov Yu, A., Kuznetsova, M.A., Kaverin, N.V., 1991. The genetic aspects of inﬂuenza
virus ﬁlamentous particle formation. Arch. Virol. 118 (3–4), 279–284.
Stuffers, S., Brech, A., Stenmark, H., 2008. ESCRT proteins in physiology and disease.
Exp. Cell Res. 315 (9), 1619–1626.
Taylor, G.M., Hanson, P.I., Kielian, M., 2007. Ubiquitin depletion and dominant-negative
VPS4 inhibit rhabdovirus budding without affecting alphavirus budding. J. Virol. 81
(24), 13631–13639.
Teo, H., Gill, D.J., Sun, J., Perisic, O., Veprintsev, D.B., Vallis, Y., Emr, S.D., Williams, R.L.,
2006. ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in
linking to ESCRT-I and membranes. Cell 125 (1), 99–111.
Utley, T.J., Ducharme, N.A., Varthakavi, V., Shepherd, B.E., Santangelo, P.J., Lindquist, M.
E., Goldenring, J.R., Crowe Jr, J.E., 2008. Respiratory syncytial virus uses a Vps4-
independent budding mechanism controlled by Rab11-FIP2. Proc. Natl. Acad. Sci.
U. S. A. 105 (29), 10209–10214.
von Schwedler, U.K., Stuchell, M., Muller, B., Ward, D.M., Chung, H.Y., Morita, E.,
Wang, H.E., Davis, T., He, G.P., Cimbora, D.M., Scott, A., Krausslich, H.G., Kaplan, J.,
278 E.A. Bruce et al. / Virology 390 (2009) 268–278Morham, S.G., Sundquist, W.I., 2003. The protein network of HIV budding. Cell
114 (6), 701–713.
Wang, M.Q., Kim, W., Gao, G., Torrey, T.A., Morse 3rd, H.C., De Camilli, P., Goff, S.P., 2003.
Endophilins interact with Moloneymurine leukemia virus Gag andmodulate virion
production. J. Biol. 3 (1), 4.
Welsch, S., Habermann, A., Jager, S., Muller, B., Krijnse-Locker, J., Krausslich, H.G., 2006.
Ultrastructural analysis of ESCRT proteins suggests a role for endosome-associatedtubular-vesicular membranes in ESCRT function. Trafﬁc (Copenhagen, Denmark) 7
(11), 1551–1566.
Williams, R.L., Urbe, S., 2007. The emerging shape of the ESCRT machinery. Nat. Rev.,
Mol. Cell. Biol. 8 (5), 355–368.
Yuan, B., Campbell, S., Bacharach, E., Rein, A., Goff, S.P., 2000. Infectivity of Moloney
murine leukemia virus defective in late assembly events is restored by late
assembly domains of other retroviruses. J. Virol. 74 (16), 7250–7260.
